National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 10038 [08-815]
Download as PDF
<![CDATA[
10038
Federal Register / Vol. 73, No. 37 / Monday, February 25, 2008 / Notices
paper copy. Comments are to be
identified with the docket number
found in brackets in the heading of this
document. The guidance and received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Please note that on January 15, 2008,
the FDA Web site transitioned to the
Federal Dockets Management System
(FDMS). FDMS is a Government-wide,
electronic docket management system.
Electronic submissions will be accepted
by FDA through FDMS only.
IV. Electronic Access
Persons with access to the Internet
may obtain the guidance document at
the following Web site: https://
www.cfsan.fda.gov/guidance.html.
Dated: February 15, 2008.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E8–3417 Filed 2–22–08; 8:45 am]
NIH, Bethesda, MD 20892, 301–496–6844,
iwl@helix.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: February 15, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–815 Filed 2–22–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–M
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
rfrederick on PROD1PC67 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, NIDDK.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Diabetes and
Digestive and Kidney Diseases,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIDDK.
Date: April 3, 2008.
Time: 8 a.m. to 6:45 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 10, 10 Center Drive, 9S235,
Bethesda, MD 20892.
Contact Person: Ira W. Levin, PhD, Chief,
Section on Molecular Biophysics, Division of
Intramural Research, National Institute of
Diabetes and Digestive, and Kidney Diseases,
VerDate Aug<31>2005
14:34 Feb 22, 2008
Jkt 214001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Non Nsaid
Action in AD.
Date: March 17, 2008.
Time: 1 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Bethesda, MD 20770 (Telephone Conference
Call).
Contact Person: Louise L. Hsu, PhD, Health
Scientist Administrator, Scientific Review
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Office, National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue/Suite
2C212, Bethesda, MD 20892, (301) 496–7705,
hsul@exmur.nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Menopause
Symptoms and Interventions.
Date: March 18, 2008.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Hotel, 8777 Georgia
Avenue, Silver Spring, MD 20910.
Contact Person: Elaine Lewis, PhD,
Scientific Review Administrator, Scientific
Review Office, National Institute on Aging,
Gateway Building, Suite 2C212, MSC–9205,
7201 Wisconsin Avenue, Bethesda, MD
20892, (301) 402–7707,
elainelewis@.nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Health Care
Productivity.
Date: April 4, 2008.
Time: 1:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Bethesda, MD 20770 (Telephone Conference
Call).
Contact Person: Wilbur C. Hadden, PhD,
Health Scientist Administrator, National
Institute on Aging, Gateway Building, Room
2C212, 7201 Wisconsin Avenue, Bethesda,
MD 20892, haddenw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: February 15, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–816 Filed 2–22–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\25FEN1.SGM
25FEN1
]]>Agencies
[Federal Register Volume 73, Number 37 (Monday, February 25, 2008)]
[Notices]
[Page 10038]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-815]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Board of Scientific Counselors, NIDDK.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Diabetes and Digestive and Kidney Diseases, including
consideration of personnel qualifications and performance, and the
competence of individual investigators, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, NIDDK.
Date: April 3, 2008.
Time: 8 a.m. to 6:45 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 10, 10 Center
Drive, 9S235, Bethesda, MD 20892.
Contact Person: Ira W. Levin, PhD, Chief, Section on Molecular
Biophysics, Division of Intramural Research, National Institute of
Diabetes and Digestive, and Kidney Diseases, NIH, Bethesda, MD
20892, 301-496-6844, iwl@helix.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: February 15, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-815 Filed 2-22-08; 8:45 am]
BILLING CODE 4140-01-M
